A biochemistry student is analyzing enzyme inhibition patterns using Lineweaver-Burk plots. When a particular inhibitor is added to the reaction mixture, the plot shows that all lines (at different inhibitor concentrations) intersect on the y-axis, with Vmax remaining unchanged but Km increasing. Which of the following is the most common type of enzyme inhibition that produces this characteristic pattern?

Explanation

## Enzyme Inhibition Patterns on Lineweaver-Burk Plots **Key Point:** Competitive inhibition is the most common type of enzyme inhibition encountered in biochemistry and clinical pharmacology. It produces a characteristic Lineweaver-Burk pattern with lines intersecting on the y-axis. ### Mechanism of Competitive Inhibition In competitive inhibition, the inhibitor competes with substrate for the active site of the enzyme. The inhibitor and substrate are mutually exclusive — only one can bind at a time. **Michaelis-Menten equation for competitive inhibition:** $$v = \frac{Vmax \cdot [S]}{Km(1 + \frac{[I]}{Ki}) + [S]}$$ **Lineweaver-Burk transformation:** $$\frac{1}{v} = \frac{Km(1 + \frac{[I]}{Ki})}{Vmax} \cdot \frac{1}{[S]} + \frac{1}{Vmax}$$ ### Lineweaver-Burk Pattern Analysis | Inhibition Type | Y-intercept (1/Vmax) | X-intercept (−1/Km) | Intersection Point | Most Common? | |---|---|---|---|---| | **Competitive** | **Unchanged** | **Shifts left (Km ↑)** | **Y-axis** | **YES** | | Non-competitive | Shifts up (Vmax ↓) | Unchanged | Left of y-axis | No | | Uncompetitive | Shifts up (Vmax ↓) | Shifts left (Km ↓) | Parallel lines | No | | Mixed-type | Shifts up (Vmax ↓) | Shifts left (Km ↑) | Right of y-axis | Rare | **High-Yield:** In competitive inhibition: - **Vmax is unchanged** (can be overcome by increasing [S]) - **Km increases** (apparent affinity decreases) - Lines intersect **on the y-axis** (characteristic signature) ### Why Competitive Inhibition is Most Common 1. **Structural similarity**: Most inhibitors structurally resemble the natural substrate 2. **Active site competition**: Direct competition at the catalytic site is the most straightforward inhibition mechanism 3. **Clinical relevance**: Many drugs work as competitive inhibitors (e.g., statins competing with HMG-CoA for HMG-CoA reductase) 4. **Reversibility**: Competitive inhibition is readily reversible by increasing substrate concentration **Clinical Pearl:** Statins (e.g., atorvastatin) are competitive inhibitors of HMG-CoA reductase. Their effect can be partially overcome by increasing dietary cholesterol or endogenous HMG-CoA levels. **Mnemonic:** **CIC = Competitive Inhibitor = Y-axis Crossing** — Competitive inhibition causes Lineweaver-Burk lines to cross on the y-axis.